Who owns BRIGHT MINDS BIOSCIENCES INC?
- Ticker: DRUG
- CUSIP Number: 10919w405
Tip: Access positions for across all investors
Analyze quarterly positions in Bright Minds Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Bright Minds Biosciences stock
Who bought or sold BRIGHT MINDS BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Henderson Group | 1.3M | $94M | 100% | Mar 2026 |
|
| Cormorant Asset Management | 1.1M | $77M | 0% | Mar 2026 |
|
| BlackRock | 622k | $45M | 58% | Mar 2026 |
|
| Vivo Capital | 557k | $41M | 11% | Mar 2026 |
|
| Braidwell | 540k | $39M | 66% | Mar 2026 |
|
| Adage Capital Partners GP | 496k | $36M | 25% | Mar 2026 |
|
| Vestal Point Capital | 492k | $36M | 100% | Mar 2026 |
|
| Driehaus Capital Management | 433k | $32M | 60% | Mar 2026 |
|
| Perceptive Advisors | 378k | $28M | -16% | Mar 2026 |
|
| Balyasny Asset Management | 297k | $22M | 32% | Mar 2026 |
|
| Deerfield Management Company | 283k | $21M | 100% | Mar 2026 |
|
| RA Capital Management | 265k | $19M | 100% | Mar 2026 |
|
| Dr. Jeffrey R. Jay, M.D. | 220k | $16M | 100% | Mar 2026 |
|
| MPM Oncology Impact Management | 212k | $16M | -8% | Mar 2026 |
|
| Ikarian Capital | 167k | $12M | 5% | Mar 2026 |
|
| Wellington Management Company | 137k | $10M | 899% | Mar 2026 |
|
| Morgan Stanley | 133k | $9.7M | 0% | Mar 2026 |
|
| Eventide Asset Management | 130k | $9.5M | 26% | Mar 2026 |
|
| Seven Grand Managers | 120k | $8.8M | 140% | Mar 2026 |
|
| Longwood Capital Partners | 112k | $8.2M | 33% | Mar 2026 |
|
| State Street Corporation | 108k | $7.9M | 40% | Mar 2026 |
|
| Geode Capital Management | 89k | $6.5M | 40% | Mar 2026 |
|
| Sio Capital Management | 86k | $6.3M | 5% | Mar 2026 |
|
| Goldman Sachs Group | 74k | $5.4M | 53% | Mar 2026 |
|
| Vanguard Portfolio Management | 61k | $4.4M | 100% | Mar 2026 |
|
| Walleye Trading Advisors | 54k | $3.9M | 108% | Mar 2026 |
|
| Millennium Management | 53k | $3.9M | -73% | Mar 2026 |
|
| Boothbay Fund Management | 51k | $3.7M | 8% | Mar 2026 |
|
| Ameriprise Financial | 50k | $3.7M | 100% | Mar 2026 |
|
| Woodline Partners | 46k | $3.3M | 100% | Mar 2026 |
|
| Parkman Healthcare Partners | 40k | $2.9M | 100% | Mar 2026 |
|
| OrbiMed Advisors | 40k | $2.9M | 100% | Mar 2026 |
|
| Artia Global Partners | 38k | $2.8M | 15% | Mar 2026 |
|
| Northern Trust | 37k | $2.7M | 46% | Mar 2026 |
|
| ADAR1 Capital Management | 34k | $2.5M | 869% | Mar 2026 |
|
| KVP Capital Advisors | 32k | $2.3M | 100% | Mar 2026 |
|
| Bank of America Corporation | 19k | $1.4M | 100% | Mar 2026 |
|
| Platinum Investment Mangement | 19k | $1.4M | -12% | Mar 2026 |
|
| D. E. Shaw & Co | 15k | $1.1M | 294% | Mar 2026 |
|
| Charles Schwab Investment Management | 15k | $1.1M | 23% | Mar 2026 |
|
| Superstring Capital Management | 13k | $971k | -72% | Mar 2026 |
|
| UBS Group | 13k | $969k | -4% | Mar 2026 |
|
| Bank of New York Mellon | 13k | $967k | 33% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 13k | $966k | -56% | Mar 2026 |
|
| AdvisorShares Investments | 13k | $920k | 27% | Mar 2026 |
|
| Sei Investments | 11k | $816k | 100% | Mar 2026 |
|
| Ghisallo Capital Management | 11k | $803k | 100% | Mar 2026 |
|
| Eudaimonia Asset Management | 9.2k | $671k | 100% | Mar 2026 |
|
| Nuveen | 8.3k | $608k | 39% | Mar 2026 |
|
| Rhumbline Advisers | 7.8k | $566k | 31% | Mar 2026 |
|
| Trexquant Investment | 7.5k | $544k | 100% | Mar 2026 |
|
| Quadrature Capital | 6.5k | $474k | 100% | Mar 2026 |
|
| LPL Financial | 6.5k | $474k | 15% | Mar 2026 |
|
| Jane Street | 6.4k | $467k | -29% | Mar 2026 |
|
| Seven Fleet Capital Management | 6.4k | $467k | 100% | Mar 2026 |
|
| Invesco | 6.3k | $459k | 50% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 6.3k | $457k | 47% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 6.1k | $442k | 100% | Mar 2026 |
|
| T. Rowe Price Associates | 4.9k | $361k | 75% | Mar 2026 |
|
| DnB NOR Asset Management AS | 4.4k | $324k | 100% | Mar 2026 |
|
| MetLife Investment Advisors | 3.9k | $285k | 34% | Mar 2026 |
|
| Florida State Board of Administration | 3.8k | $276k | 0% | Mar 2026 |
|
| Mirae Asset Global Etfs Holdings | 3.3k | $238k | 40% | Mar 2026 |
|
| Susquehanna International | 3.1k | $229k | 100% | Mar 2026 |
|
| Virtu Financial | 3.1k | $228k | 8% | Mar 2026 |
|
| Barclays | 3.1k | $225k | -68% | Mar 2026 |
|
| Vanguard Global Advisers | 3.1k | $223k | 100% | Mar 2026 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.7k | $197k | 200% | Mar 2026 |
|
| New York State Common Retirement Fund | 2.6k | $190k | 0% | Mar 2026 |
|
| Wells Fargo & Company | 2.5k | $185k | -54% | Mar 2026 |
|
| Persistent Asset Partners | 2.3k | $169k | 100% | Mar 2026 |
|
| Aquatic Capital Management | 2.0k | $149k | 100% | Mar 2026 |
|
| Police & Firemen's Retirement System of New Jersey | 2.0k | $149k | 35% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.6k | $115k | -94% | Mar 2026 |
|
| Russell Investments | 882.00 | $64k | -6% | Mar 2026 |
|
| FMR | 819.00 | $60k | -26% | Mar 2026 |
|
| Legal & General Group | 616.00 | $45k | 13% | Mar 2026 |
|
| China Universal Asset Management | 600.00 | $42k | 20% | Jun 2026 |
|
| Tower Research Capital | 597.00 | $44k | -45% | Mar 2026 |
|
| Summit Investment Advisors | 470.00 | $34k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 406.00 | $30k | 100% | Mar 2026 |
|
| California State Teachers Retirement System | 380.00 | $28k | 23% | Mar 2026 |
|
| Citigroup | 297.00 | $22k | 100% | Mar 2026 |
|
| Goss Wealth Management | 250.00 | $18k | 400% | Mar 2026 |
|
| Sterling Capital Management | 26.00 | $1.8k | -42% | Jun 2026 |
|
| GAMMA Investing | 20.00 | $1.4k | -39% | Jun 2026 |
|
| CWM | 11.00 | $803.000000 | 10% | Mar 2026 |
|
| Bell Investment Advisors | 6.00 | $438.000000 | 100% | Mar 2026 |
|
| SBI Securities | 5.00 | $365.000000 | 0% | Mar 2026 |
|
| Hanson McClain Advisors | 3.00 | $219.000000 | 100% | Mar 2026 |
|
| Twin Peaks Wealth Advisors | 1.00 | $73.000000 | 100% | Mar 2026 |
|
| MAI Wealth Advisors | 1.00 | $73.000000 | 100% | Mar 2026 |
|
Who sold out of Bright Minds Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Stempoint Capital | Dec 2025 | 97k | $7.6M |
| Commodore Capital | Dec 2025 | 19k | $1.5M |
| Marshall Wace | Dec 2025 | 4.6k | $359k |
| Two Sigma Investments | Dec 2025 | 2.6k | $203k |
| Advisor Group Holdings | Dec 2025 | 371.00 | $29k |